ANI Pharmaceuticals, Inc. (ANIP)
73.15
-0.01
(-0.01%)
USD |
NASDAQ |
Oct 30, 11:39
ANI Pharmaceuticals Total Return Level : 73.16 for Oct. 29, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 29, 2026 | 73.16 |
| October 28, 2026 | 71.71 |
| October 27, 2026 | 71.17 |
| October 26, 2026 | 72.60 |
| October 23, 2026 | 72.61 |
| October 22, 2026 | 73.75 |
| October 21, 2026 | 72.24 |
| October 20, 2026 | 72.67 |
| October 19, 2026 | 72.56 |
| October 16, 2026 | 72.29 |
| October 15, 2026 | 72.28 |
| October 14, 2026 | 70.16 |
| October 13, 2026 | 70.84 |
| October 12, 2026 | 73.59 |
| October 09, 2026 | 73.89 |
| October 08, 2026 | 71.98 |
| October 07, 2026 | 71.93 |
| October 06, 2026 | 71.52 |
| October 05, 2026 | 72.58 |
| October 02, 2026 | 72.18 |
| October 01, 2026 | 72.96 |
| September 30, 2026 | 72.65 |
| September 29, 2026 | 72.62 |
| September 28, 2026 | 74.83 |
| September 25, 2026 | 74.00 |
| Date | Value |
|---|---|
| September 24, 2026 | 74.04 |
| September 23, 2026 | 74.43 |
| September 22, 2026 | 77.91 |
| September 21, 2026 | 78.85 |
| September 18, 2026 | 76.14 |
| September 17, 2026 | 75.39 |
| September 16, 2026 | 73.59 |
| September 15, 2026 | 72.11 |
| September 14, 2026 | 70.40 |
| September 11, 2026 | 70.19 |
| September 10, 2026 | 71.46 |
| September 09, 2026 | 70.70 |
| September 08, 2026 | 70.23 |
| September 04, 2026 | 71.23 |
| September 03, 2026 | 71.99 |
| September 02, 2026 | 73.06 |
| September 01, 2026 | 71.92 |
| August 31, 2026 | 73.25 |
| August 28, 2026 | 72.83 |
| August 27, 2026 | 73.51 |
| August 26, 2026 | 74.56 |
| August 25, 2026 | 75.65 |
| August 24, 2026 | 74.17 |
| August 21, 2026 | 75.35 |
| August 20, 2026 | 77.32 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Eli Lilly & Co. | 3629.60 |
| Ocular Therapeutix, Inc. | 7.31 |
| Liquidia Corp. | 44.99 |
| Elanco Animal Health, Inc. | 23.24 |
| Harmony Biosciences Holdings, Inc. | 38.59 |